Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   
The JSE is currently experiencing technical difficulties and are intermittently not shipping JSE Index updates.
Aspen Pharmacare Holdings Ltd.  –  JSE:APN    
     
Prices at least 15 minutes delayed. Source: JSE Ltd.
 
 
 
 
Zoom: 
1D 2D 3M 1Y 3Y 5Y 10Y
JSE Overall 71 265 2.18%
Pharma & Biotech 15 034 1.28%
 
More performance data
10 Day Trading Range
141.01 153.45
Peer Comparison
ASPEN (APN)152.00 (1.32%)
ADCOCK (AIP)51.32 (0.63%)
ASCENDIS (ASC)0.70 (-2.78%)
NUTRITION (NUT)0.01 (-96.00%)
GO LIFE (GLI)0.02 (0.00%)
Customise
Analysts' positions on APN
Detailed forecasts
Visual Calendar for APN
APN Calendar Table
Institutional Support for APN
Jun 2022 quarter -13.93%
Mar 2022 quarter -17.01%
Unit Trust Holdings
Sector: Pharmaceuticals and Biotechnology
 
APN  Latest Market Data
Yesterday's Close152.00   P/E Ratio10.78
Yesterday's Open150.00   EPS - TTM 1 410.50
Best Bid   DPS - TTM Dividend (cps) 262 262
Best Offer   Dividend Yield 1.72
Yesterday's Volume 955 411   Market Cap 67.83bn
Yesterday's Range148.72–153.45   Shares In Issue 446.25m
Detailed quote
Latest SENS Latest News
Latest Results for APN
6 months ended Dec 2021 (published Mar 2022) Interim
(ZAR million)%chgDec 21 Dec 20
Turnover4.0% 19 381.0 18 633.0
Attributable Income31.8% 3 360.0 2 549.0
Market Cap (ZARm)79.0% 102 456.9 57 231.4
EPS (ZARc)31.8% 736.20 558.40
HEPS (Cont Ops)(ZARc)36.1% 777.20 571.00
DPS (ZARc)---
View Comment Detailed financials
 
Nature of Business
Aspen Pharmacare Holdings Ltd, is a South African-based global specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The Group's Commercial Pharmaceuticals business comprises Sterile Focus and Regional Brands. Aspen has invested in strategically relevant manufacturing capacity and has capabilities across biological and chemical APIs, orals, liquids, topicals and steriles, at 23 manufacturing facilities on 6 continents.
Company Factsheet
 
Portfolio  
Watch List  
Recently viewed
 
 
* Price data source: JSE Ltd. All other statistics calculated by ProfileData.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2022  ]
  


Powered by ProfileData


Follow us on: